Waypoint Wealth Counsel Pfizer Inc Transaction History

Waypoint Wealth Counsel

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Apr 03, 2024	SELL	$26.13 - $33.94 $63,913 - $83,017	-2,446 Reduced 23.29%	8,057 $232 Million
Q3 2023 Apr 03, 2024	BUY	$32.09 - $37.51 $4,428 - $5,176	138 Added 1.33%	10,503 $348 Million
Q2 2023 Apr 02, 2024	SELL	$36.12 - $41.79 $186,270 - $215,511	-5,157 Reduced 33.22%	10,365 $380 Million
Q1 2023 Apr 04, 2024	BUY	$39.39 - $51.28 $92,684 - $120,661	2,353 Added 29.2%	10,410 $425 Million
Q4 2022 Mar 22, 2024	BUY	$41.75 - $54.5 $648,043 - $845,949	15,522 New	15,522 $795 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Waypoint Wealth Counsel, based on Form 13F filings with the SEC.

Stay updated on Waypoint Wealth Counsel with notifications on news.